Guess which 2 ASX All Ordinaries shares were the best and worst performers of FY24?

There are 500 companies within the ASX All Ordinaries Index. Here are the top and tail stocks of FY24.

| More on:
best and worse asx shares represented by green best button and red worst button

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX All Ordinaries Index (ASX: XAO) is slightly in the red on Friday, down 0.11%.

There are 500 companies within the ASX All Ords index.

We thought it might be interesting to see which ASX All Ords share delivered the best capital growth in FY24 and which one languished at the bottom of the pile.

The results are in.

Best ASX All Ords share of FY24 for growth

Clarity Pharmaceuticals Ltd (ASX: CU6)

ASX All Ords healthcare share Clarity Pharmaceuticals shot the lights out in FY24. The Clarity Pharmaceuticals share price soared by 674.29% over the 12 months.

Clarity is a clinical-stage radiopharmaceutical company. It's developing next-generation therapy and imaging products used for the diagnosis and treatment of cancer and other serious diseases.

The majority of the stock's impressive price ascension in FY24 began in April.

That's when the company announced that the first patient ever to be dosed with two cycles of 67Cu-SAR-bisPSMA at 8GBq had a complete response to treatment based on RECIST criteria.

That meant the patient had maintained undetectable levels of prostate cancer for almost six months.

In March, Clarity successfully completed an institutional capital raising of $110 million. It then ran a fully underwritten retail entitlement offer at $2.55 per share, which raised a further $10.8 million.

The funds will be used to continue radiopharmaceutical product development.

Last month, Clarity announced it had received a near-$10 million research and development tax incentive refund as part of the Australian Federal Government's R&D Tax Incentive program.

The Clarity Pharmaceuticals share price closed FY24 at $5.42.

Worst ASX All Ords share of FY24

Core Lithium Ltd (ASX: CXO)

The share price of ASX All Ords lithium share Core Lithium tanked by 90% in FY24.

Just a year ago on 30 June 2023, Core Lithium shares were worth 90 cents a piece. That was already a devastating 52% fall from their all-time record high of $1.875 on 13 November 2022.

On the final trading day of FY24, the Core Lithium share price closed at 9.35 cents. So, it's not surprising that the stock was at the bottom of the ASX All Ords index for FY24.

The biggest news out of the company in FY24 was the suspension of mining at its flagship Finniss Project in the Northern Territory in January.

The company did this to conserve capital while lithium prices continued to fall. Since then, Core Lithium has continued analysing exploration results and processing stockpiled ore.

In the latest quarterly update, Core Lithium told investors its cash balance had reduced from $124.8 million at the end of December to $80.4 million at the end of March.

However, the company said it intended to sell an inventory of lithium concentrate and fines in 4Q FY24. At the time of the announcement, it valued the inventory at $25 million.

Motley Fool contributor Bronwyn Allen has positions in Core Lithium. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A group of young ASX investors sitting around a laptop with an older lady standing behind them explaining how investing works.
Broker Notes

10 ASX shares to buy in FY25

Analysts say investors should buy these stocks in the new financial year.

Read more »

A woman stacks smooth round stones into a pile by a lake.
Share Market News

Here's how the ASX 200 market sectors stacked up last week

ASX energy shares had a cracking week with a 4.07% uplift thanks to higher commodity prices.

Read more »

Contented looking man leans back in his chair at his desk and smiles.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Three rockets heading to space
Share Gainers

These top 3 ASX 200 uranium shares went nuclear in FY24

Strong global demand and a rising uranium commodity price were tailwinds for these stocks in FY24.

Read more »

A man has a surprised and relieved expression on his face. as he raises his hands up to his face in response to the high fluctuations in the Galileo share price today
Broker Notes

These ASX shares can rise 25% to 40%

Analysts think these shares could deliver big returns for investors.

Read more »

An unhappy investor holding his eyes while watching a falling ASX share price on a computer screen.
Materials Shares

Why did the Core Lithium share price crash 90% in FY 2024

Core Lithium shares were in a sharp downtrend throughout FY 2024. But why?

Read more »

A woman with strawberry blonde hair has a huge smile on her face and fist pumps the air having seen good news on her phone.
Broker Notes

Bell Potter names 3 of the best ASX 200 stocks to buy in July

These shares have been given a big thumbs up by the broker this month.

Read more »

Five young people celebrate outside with sparklers
Share Gainers

Best 5 ASX 200 energy shares for price growth in FY24

There are three uranium stocks, a coal stock and an oil stock in the mix.

Read more »